| Transcutaneous vaccines--current and emerging strategies. | |
| | |
MedLine Citation:
|
PMID: 23316778 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vaccination, which is the major fundamental prophylaxis against illness and death from infectious disease, has greatly contributed to the global improvement of human health. However, the disadvantages of conventional injection systems hamper the delivery of vaccination technologies to developing countries. The imminent practice of easy-to-use vaccination methods is expected to overcome certain issues associated with injectable vaccinations. One innovative method is the transcutaneous immunization (TCI) system. AREAS COVERED: Two major strategies for TCI are discussed in this review. One is to promote antigen permeation of the skin barrier by patch systems or nanoparticles. The other is the delivery of antigens into the skin by electroporation and microneedles in order to physically overcome the skin barrier. Moreover, adjuvant development for TCI is discussed. EXPERT OPINION: Many different approaches have been developed for TCI, which have the potential to be effective, easy-to-use and painless methods of vaccination. However, in practical terms, the guidelines concerning the manufacturing processes and clinical trial evaluation of the procedures have not kept pace with the development of these novel formulations. The accumulation of information regarding skin characteristics and the properties of TCI devices will help refine TCI system development guidelines and thus lead to the improvement of transcutaneous vaccination. |
| | |
Authors:
|
Sachiko Hirobe; Naoki Okada; Shinsaku Nakagawa |
Related Documents
:
|
3653518 - Localization of polysialoglycoprotein as a major glycoprotein component in cortical alv... 23499608 - Qualitative responses to a national physician survey on hpv vaccination. 18670878 - Variation of acharan sulfate and monosaccharide composition and analysis of neutral n-g... 12606378 - Late onset of spermatogenesis and gain of fertility in pog-deficient mice indicate that... 3653518 - Localization of polysialoglycoprotein as a major glycoprotein component in cortical alv... 17010038 - Persistence of rabbit haemorrhagic disease virus genome in vaccinated rabbits after exp... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review Date: 2013-01-15 |
Journal Detail:
|
Title: Expert opinion on drug delivery Volume: 10 ISSN: 1744-7593 ISO Abbreviation: Expert Opin Drug Deliv Publication Date: 2013 Apr |
Date Detail:
|
Created Date: 2013-03-15 Completed Date: 2013-05-17 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 101228421 Medline TA: Expert Opin Drug Deliv Country: England |
Other Details:
|
Languages: eng Pagination: 485-98 Citation Subset: IM |
Affiliation:
|
Osaka University, Graduate School of Pharmaceutical Sciences, Laboratory of Biotechnology and Therapeutics, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adjuvants, Immunologic
/
administration & dosage Administration, Cutaneous Animals Antigens / administration & dosage, immunology Chemistry, Pharmaceutical Developing Countries Electroporation Humans Immunization / methods Nanoparticles / administration & dosage Skin / immunology Technology, Pharmaceutical / trends* Transdermal Patch* Vaccination / methods* Vaccines / administration & dosage* |
| Chemical | |
Reg. No./Substance:
|
0/Adjuvants, Immunologic; 0/Antigens; 0/Vaccines |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quadriplegia in a child following adenotonsillectomy.
Next Document: Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the saf...